Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Analysis, Animal models, Assay development optimisation & technology, Business, Cell / tissue culture, Cell culture, Cellular & Molecular biology, Cellular assays, Chemical engineering, Clinical specialities, Clinical trials, Drug development, Drug discovery, Enabling technologies, High Content Screening, High throughput screening, Imaging, Lead discovery, Microbiome, Oncology, Pharmokinetics, Preclinical, RNA, Screening, Sequencing, Stem cells, System biology, Systems biology, Therapeutics, Toxicology
